I served as CTO and CPO of
Qairnel, building platforms that help pharmaceutical companies accelerate and de-risk their neurology clinical trials, especially in Alzheimer’s disease. Our work combined:
- Product & operations: large-scale recruitment of prescreened patients through DocMemo.com and DocMemo.fr.
- AI: models that match participants’ profiles to open trials and support inclusion decisions.